Article Versions Notes

Ullah A, Ahmad S, Ali N, Rahman SU, Hussain H, Alghamdi S, Almehmadi M, Dablool AS, Bannunah AM, Bukhari SH, et al. Insulinotropic Potential of Moxifloxacin and Gemifloxacin: An In Vivo Rabbits Model Study Followed by Randomized Phase I Clinical Trial. Antibiotics. 2022; 11(2):148. https://doi.org/10.3390/antibiotics11020148

Ullah, Abid, Shujaat Ahmad, Niaz Ali, Shafiq Ur Rahman, Haya Hussain, Saad Alghamdi, Mazen Almehmadi, Anas S. Dablool, Azzah M. Bannunah, Syeda Hajira Bukhari, and et al. 2022. "Insulinotropic Potential of Moxifloxacin and Gemifloxacin: An In Vivo Rabbits Model Study Followed by Randomized Phase I Clinical Trial" Antibiotics 11, no. 2: 148. https://doi.org/10.3390/antibiotics11020148

Ullah, A., Ahmad, S., Ali, N., Rahman, S. U., Hussain, H., Alghamdi, S., Almehmadi, M., Dablool, A. S., Bannunah, A. M., Bukhari, S. H., & Almarshad, F. (2022). Insulinotropic Potential of Moxifloxacin and Gemifloxacin: An In Vivo Rabbits Model Study Followed by Randomized Phase I Clinical Trial. Antibiotics, 11(2), 148. https://doi.org/10.3390/antibiotics11020148